Brain Health Devices Market - Global Brain Health Devices Systems Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

The global brain health devices market is poised for substantial expansion, with a projected CAGR of 4% during the period from 2023 to 2030. By 2030, the market value is estimated to reach approximately US$18 billion, marking significant growth from the US$10 billion recorded in 2022.

Brain health devices encompass a diverse range of technological tools and equipment designed to monitor, assess, enhance, and support cognitive well-being and neurological function. These devices serve various aspects of brain health, including diagnosing neurological disorders, improving cognitive function, managing stress, and promoting overall mental well-being. The brain health devices market has witnessed remarkable expansion due to increased awareness of cognitive health, technological advancements, and a growing demand for innovative solutions to address neurological disorders. This dynamic market includes a wide array of devices aimed at monitoring, diagnosing, treating, and optimizing brain function, catering to individuals of all age groups, from children to the elderly.

Growth Drivers

Improving Rate of Diagnosis: Advances in neurodiagnostics contribute to the market's growth. Patients' increasing focus on early disease detection and the proliferation of diagnostic centers and hospitals support market momentum. Greater patient awareness about neurological diseases, coupled with government and healthcare provider support for awareness, diagnostics, and treatment, bolster market growth.

COVID-19 Impact: The pandemic heightened awareness of mental health, leading to increased demand for brain health devices that support and monitor mental well-being. Telehealth and remote patient monitoring gained momentum during the pandemic, fostering interest in remote brain health solutions. Innovation and research in brain health devices for home and remote use accelerated in response to the pandemic.

Surging Cases of Traumatic Brain Injuries and Neurological Disorders: Traumatic brain injuries, neurological disorders, Alzheimer's disease, and stroke cases are on the rise, driving the demand for brain health devices. Factors such as aging populations, obesity, hypertension, diabetes, and cardiovascular diseases contribute to neurological disorders and strokes.

Strong Government Backing: Government initiatives worldwide play a crucial role in advancing brain health technologies, research, awareness campaigns, and accessibility enhancements. Notable examples include the World Health Organization's Intersectoral Global Action Plan (IGAP) to improve epilepsy and neurological disorder care and numerous collaborative clinical trials focusing on non-invasive brain health monitoring.

Growth Challenges

High Costs and Complexities in Brain Monitoring: Brain monitoring procedures often require skilled therapists and come with high equipment and personnel costs. The complexity of certain devices like continuous EEG monitoring limits their adoption due to expenses and the need for qualified experts to interpret data.

Growth Opportunities

North America Surges Ahead: North America, with its robust healthcare infrastructure, research focus, and regulatory frameworks, is expected to lead the market. Product approvals from the US FDA and innovation by companies like Google and Microsoft in wearable brain devices contribute to the region's growth.

Developing Economies Gear up to Enter the Fray: The Asia Pacific region shows significant growth potential, driven by government initiatives, medical tourism, research activities, and increased awareness of mental wellness. Growing use of advanced diagnostics and rising awareness of mental health in the region are also expected to boost market growth.

Competitive Landscape Analysis

Key players engaged in marketing, research, and development of brain health products include Philips Group, GE Healthcare, Medtronic Plc, Siemens Healthineers, Integra Lifesciences, Bioserenity, Neuroelectrics, Cognionics Inc., Advanced Brain Monitoring, Inc., Edwards Lifesciences Corporation, Neurosoft, Masimo Corporation, and Natus Medical Inc.


This product will be delivered within 1-3 business days.